자유게시판

• 목록
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and [empty] Breastfeeding

Women suffering from ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these drugs can affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need genetic testing for adhd medications more high-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to consider the benefits of taking it against the possible risks for the foetus. The doctors don't have the information to make unambiguous recommendations however they can provide information on risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to make sure that the classification was accurate and to minimize any bias.

The research conducted by the researchers had some limitations. Researchers were unable in the beginning, to separate the effects triggered by the medication from the disorder. That limitation makes it difficult to know whether the small differences observed in the groups that were exposed result from medication use or comorbidities that cause confusion. The researchers also did not examine long-term outcomes for the offspring.

The study did find that babies whose mothers had taken ADHD medications during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These risks did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications in early pregnancies may be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman’s disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies for improving their coping skills which can reduce the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether or not to end treatment during pregnancy is a question that doctors are having to face. most common adhd medications of the time, these decisions are made in the absence of solid and reliable evidence regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what research suggests about the subject and their best judgment for each individual patient.

The issue of potential risks for infants can be particularly tricky. The research that has been conducted on this topic is based on observations rather than controlled studies, and many of the findings are conflicting. In addition, most studies limit their analysis to live births, which could undervalue the serious teratogenic effects that can general practitioners prescribe adhd medication lead to abortion or termination of the pregnancy. The study presented in this journal club addresses these shortcomings by analyzing data on live and deceased births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects, other studies have not established a link. The majority of studies show that there is a neutral, or somewhat negative, impact. In every case it is imperative to conduct a thorough analysis of the risks and benefits is required.

For a lot of women with ADHD and ADD, the decision to stop taking medication can be difficult, if not impossible. In an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping adhd and medication medication given for adhd during pregnancy can cause depression, feelings of isolation, [Redirect-302] and family conflict for these patients. Furthermore, a loss of medication can affect the ability to complete jobs and drive safely which are essential aspects of daily life for a lot of people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy educate family members, coworkers and their friends about the condition, its effects on daily functioning, and the benefits of continuing the current treatment. In addition, educating them can help the woman feel supported in her struggle with her decision. It is also worth noting that certain drugs can pass through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be transferred to the child.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns over the impact that these medications could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two huge data sets to examine more than 4.3 million pregnant women and determine whether stimulant medications caused birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medicines was associated with an increased risk of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers behind the study found no link between early medication use and other congenital abnormalities, like facial clefting, or club foot. The results are consistent with previous studies revealing an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications before the birth of their child. The risk increased in the latter half of pregnancy when a large number of women decided to stop taking their medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby who needed breathing assistance during birth. The authors of the study were not able to remove bias in selection since they restricted the study to women without other medical conditions that might have contributed to the findings.

Researchers hope their research will inform physicians when they see pregnant women. The researchers advise that, while discussing benefits and risks are important, the choice about whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and her needs.

The authors also warn that while discontinuing the medications is an option, it isn't a recommended practice because of the high rate of depression and other mental health issues among women who are pregnant or who are recently post-partum. Furthermore, research suggests that women who choose to stop taking their medication are more likely to experience a difficult time adapting to life without them after the baby's arrival.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD who have to manage their symptoms while attending doctor appointments, getting ready for the arrival of their child and adjusting to new household routines can experience severe challenges. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed by breast milk in small amounts, therefore the risk to the nursing infant is very low. However, the frequency of exposure to medication by the newborn may differ based on the dosage, frequency it is taken and the time of day it is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't fully understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. It is a difficult decision for the mother, who must weigh the advantages of continuing her medication against the potential risks to the embryo. As long as more information is available, doctors can inquire about pregnant patients whether they have an history of ADHD or if they are planning to take medication during the perinatal phase.

A growing number of studies have shown that the majority of women are able to safely continue their ADHD medication during pregnancy and while breastfeeding. This has led to many patients opt to do this, and after consulting with their doctor, they have discovered that the benefits of keeping their current medication far outweigh any risks.

It's important for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their physician and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be informed about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach including obstetricians, GPs, and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regime.